Search research articles
Contact Us
Filters
Showing results (371-380 of 385) with videos related to
Page
of 39
Sort By:
Leukemia
|
May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Gerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2002
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma
Ulrich Kaiser, Irmgard Uebelacker, Ulrich Abel, et al.
Hemasphere
|
July 10, 2023
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial
Gerhard Held, Lorenz Thurner, Viola Poeschel, et al.
Blood Advances
|
December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP
Onur Cetin, Igor Age Kos, Evi Regitz, et al.
Blood Cancer Journal
|
July 5, 2024
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years
Philipp Berning, Mathilde Fekom, Maud Ngoya, et al.
Lancet (London, England)
|
October 25, 2017
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
Peter Borchmann, Helen Goergen, Carsten Kobe, et al.
Blood
|
April 29, 2015
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV
Susanne Saussele, Marie-Paloma Krauss, Rüdiger Hehlmann, et al.
The Lancet. Oncology
|
February 14, 2016
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2019
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
Andreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
Blood
|
January 29, 2021
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL
Norbert Schmitz, Lorenz Truemper, Krimo Bouabdallah, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 385) with videos related to
Sort By:
Page
of 39
Leukemia
|
May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Gerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2002
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma
Ulrich Kaiser, Irmgard Uebelacker, Ulrich Abel, et al.
Hemasphere
|
July 10, 2023
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial
Gerhard Held, Lorenz Thurner, Viola Poeschel, et al.
Blood Advances
|
December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP
Onur Cetin, Igor Age Kos, Evi Regitz, et al.
Blood Cancer Journal
|
July 5, 2024
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years
Philipp Berning, Mathilde Fekom, Maud Ngoya, et al.
Lancet (London, England)
|
October 25, 2017
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
Peter Borchmann, Helen Goergen, Carsten Kobe, et al.
Blood
|
April 29, 2015
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV
Susanne Saussele, Marie-Paloma Krauss, Rüdiger Hehlmann, et al.
The Lancet. Oncology
|
February 14, 2016
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2019
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
Andreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
Blood
|
January 29, 2021
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL
Norbert Schmitz, Lorenz Truemper, Krimo Bouabdallah, et al.
Page
of 39